好孕家精沛優膜衣錠
好孕家精沛優膜衣錠 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
- Registration number
- 1119051291
- Chinese name
- 好孕家精沛優膜衣錠
- English name
- DOUBLELINE ANDROFERITLE TABLETS
- Type
- Imported tablets and capsules
- Published status
- Status not provided in this export; the validity date is shown separately
- Licence holder
- 登康生技有限公司
- Registration date
- 2022-11-01
- Published validity end
- 2027-11-01
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
règlement (UE) 2022/63. Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| BIOTIN | BIOTIN | Biotine (vitamine B8) |
| GLUTATHIONE | GLUTATHIONE | Not identified |
| VITAMIN C (ASCORBIC ACID) | VITAMIN C (ASCORBIC ACID) | Vitamine C |
| MICROCRYSTALLINE CELLULOSE | MICROCRYSTALLINE CELLULOSE | Not identified |
| D-MANNITOL | D-MANNITOL | Not identified |
| SILICON DIOXIDE | SILICON DIOXIDE | Not identified |
| CALCIUM PHOSPHATE, TRIBASIC | CALCIUM PHOSPHATE, TRIBASIC | Calcium |
| STEARIC ACID | STEARIC ACID | Acide stéarique |
| HYDROXYPROPYL METHYLCELLULOSE | HYDROXYPROPYL METHYLCELLULOSE | Not identified |
| PURIFIED WATER | PURIFIED WATER | Not identified |
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | Not identified |
| VITAMIN B12 (METHYLCOBALAMIN) | VITAMIN B12 (METHYLCOBALAMIN) | Vitamine B12 |
| BRILLIANT BLUE FCF | BRILLIANT BLUE FCF | Not identified |
| FOLIC ACID | FOLIC ACID | Folates (vitamine B9) |
| ZINC CITRATE | ZINC CITRATE | Zinc |
| D-ALPHA-TOCOPHERYL ACID SUCCINATE | D-ALPHA-TOCOPHERYL ACID SUCCINATE | Vitamine E |
| SELENIUM YEAST | SELENIUM YEAST | Sélénium |
| L-ARGININE | L-ARGININE | Not identified |
| L-CARNITINE | L-CARNITINE | L-carnitine |
| COENZYME Q10 | COENZYME Q10 | Ubiquinone |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Product name
- 好孕家精沛優膜衣錠
- Active ingredients
- BIOTIN;;GLUTATHIONE;;VITAMIN C (ASCORBIC ACID);;MICROCRYSTALLINE CELLULOSE;;D-MANNITOL;;SILICON DIOXIDE;;CALCIUM PHOSPHATE, TRIBASIC;;STEARIC ACID;;HYDROXYPROPYL METHYLCELLULOSE;;PURIFIED WATER;;TITANIUM DIOXIDE;;VITAMIN B12 (METHYLCOBALAMIN);;BRILLIANT BLUE FCF;;FOLIC ACID;;ZINC CITRATE;;D-ALPHA-TOCOPHERYL ACID SUCCINATE;;SELENIUM YEAST;;L-ARGININE;;L-CARNITINE;;COENZYME Q10;;
- Valid until
- 1161101
- Registration number
- 1119051291
- Licence holder
- 登康生技有限公司
- Registration date
- 1111101
- Published reference
- DHC0B190512912
- Published English name
- DOUBLELINE ANDROFERITLE TABLETS
Official source
View the official register, number 1119051291
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
Open Government Data License, version 1.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- L-CARNITINE
Read the warning, when it applies and the studies cited
L-CARNITINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (CPS 2008).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a seizure disorder (CPS 2008).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- COENZYME Q10
Read the warning, when it applies and the studies cited
Coenzyme Q10 (UBIQUINONE-10)
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 100 mg of Coenzyme Q10 per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Migraine prophylaxis/prevention.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.